The Prognostic Relevance of the Proliferation Markers Ki-67 and Plk1 in Early-Stage Ovarian Cancer Patients With Serous, Low-Grade Carcinoma Based on mRNA and Protein Expression

Since type and duration of an appropriate adjuvant chemotherapy in early-stage ovarian cancer (OC) are still being debated, novel markers for a better stratification of these patients are of utmost importance for the design of an improved chemotherapeutical strategy. In contrast to numerous cancer s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rödel, Franz, Zhou, Shengtao, Győrffy, Balász, Raab, Monika, Sanhaji, Mourad, Mandal, Ranadip, Martin, Daniel, Becker, Sven, Strebhardt, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577119/
https://www.ncbi.nlm.nih.gov/pubmed/33117692
http://dx.doi.org/10.3389/fonc.2020.558932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577119/
https://www.ncbi.nlm.nih.gov/pubmed/33117692
http://dx.doi.org/10.3389/fonc.2020.558932

Ejemplares similares